As the world continues to grapple with the ongoing COVID-19 pandemic, new questions have emerged about the origin of the virus and whether one of its more pathogenic variants, Delta, may have originated from Pfizer Inc.'s India operations.
A Pfizer executive claims in a video that the company had been exploring ways to "mutate" the coronavirus via "directed evolution" by experimenting on monkeys and the Delta variant, which is more contagious, was discovered in India a month after Pfizer announced its monkey research.
“Promise you won’t tell anyone. The way [the experiment] would work is that we put the virus in monkeys, and we successively cause them to keep infecting each other, and we collect serial samples from them," the Pfizer executive says.
Dr. Paul Offit, a member of the U.S. FDA’s vaccine advisory committee, has written in the New England Journal of Medicine, the world’s top medical journal, calling for an end to the mass vaccination of anyone at low risk from the virus.
New York City health officials are warning residents that the infectious omicron subvariant XBB.1.5 may be more likely to infect people who have already been vaccinated or infected with COVID-19.
The American Heart Association invalidated fact-checkers and big tech yet again this week when the organization published research suggesting the spike protein in vaccines can hurt some people.
